Reduction of Connexin36 Content by ICER-1 Contributes to Insulin-Secreting Cells Apoptosis Induced by Oxidized LDL Particles

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Haefliger, Jacques Antoine ^a   Martin, David ^a   Favre, Dimitri ^b   Petremand, Yannick ^b   Mazzolai, Lucia ^a   Abderrahmani, Amar ^c   Meda, Paolo ^d   Waeber, Gérard ^a   Allagnat, Florent ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIV LILLE   (France)

^d UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 36; INDUCIBLE CYCLIC AMP EARLY REPRESSOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PERILIPIN; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; AZO COMPOUNDS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL LINE; CONNEXINS; CYCLIC AMP RESPONSE ELEMENT MODULATOR; DNA PRIMERS; GENE EXPRESSION REGULATION; HUMANS; HYPERCHOLESTEROLEMIA; INSULIN-SECRETING CELLS; LIPOPROTEINS, LDL; LUCIFERASES; MICE; MICE, KNOCKOUT; PHOSPHOPROTEINS; RATS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84873844411     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055198     Document Type: Article

References (51)

1. Todd JA, (2010) Etiology of type 1 diabetes. Immunity 32: 457-467.
2. Wajchenberg BL, (2007) beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev 28: 187-218.
3. Bosco D, Haefliger JA, Meda P, (2011) Connexins: key mediators of endocrine function. Physiol Rev 91: 1393-1445.
4. Allagnat F, Alonso F, Martin D, Abderrahmani A, Waeber G, et al. (2008) ICER-1gamma overexpression drives palmitate-mediated connexin36 down-regulation in insulin-secreting cells. J Biol Chem 283: 5226-5234.
5. Le Gurun S, Martin D, Formenton A, Maechler P, Caille D, et al. (2003) Connexin-36 contributes to control function of insulin-producing cells. J Biol Chem 278: 37690-37697.
6. Hamelin R, Allagnat F, Haefliger JA, Meda P, (2009) Connexins, diabetes and the metabolic syndrome. Curr Protein Pept Sci 10: 18-29.
7. Klee P, Allagnat F, Pontes H, Cederroth M, Charollais A, et al. (2011) Connexins protect mouse pancreatic beta cells against apoptosis. J Clin Invest 121: 4870-4879.
8. Allagnat F, Martin D, Condorelli DF, Waeber G, Haefliger JA, (2005) Glucose represses connexin36 in insulin-secreting cells. J Cell Sci 118: 5335-5344.
9. Berneis K, Jeanneret C, Muser J, Felix B, Miserez AR, (2005) Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes. Metabolism 54: 227-234.
10. Heinecke JW, (2006) Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander? J Exp Med 203: 813-816.
11. Rohrer L, Hersberger M, von Eckardstein A, (2004) High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol 15: 269-278.
12. Williams KJ, Fisher EA, (2005) Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory? Curr Opin Clin Nutr Metab Care 8: 139-146.
13. Nakhjavani M, Esteghamati A, Khalilzadeh O, Asgarani F, Mansournia N, et al. (2010) Association of macroalbuminuria with oxidized LDL and TGF-beta in type 2 diabetic patients: a case-control study. Int Urol Nephrol 42: 487-492.
14. Nakhjavani M, Khalilzadeh O, Khajeali L, Esteghamati A, Morteza A, et al. (2010) Serum oxidized-LDL is associated with diabetes duration independent of maintaining optimized levels of LDL-cholesterol. Lipids 45: 321-327.
15. Taskinen MR, (2003) LDL-cholesterol, HDL-cholesterol or triglycerides-which is the culprit? Diabetes Res Clin Pract 61Suppl 1: S19-26.
16. Roehrich ME, Mooser V, Lenain V, Herz J, Nimpf J, et al. (2003) Insulin-secreting beta-cell dysfunction induced by human lipoproteins. J Biol Chem 278: 18368-18375.
17. Cnop M, Hannaert JC, Grupping AY, Pipeleers DG, (2002) Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification. Endocrinology 143: 3449-3453.
18. Abderrahmani A, Niederhauser G, Favre D, Abdelli S, Ferdaoussi M, et al. (2007) Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells. Diabetologia 50: 1304-1314.
19. Favre D, Niederhauser G, Fahmi D, Plaisance V, Brajkovic S, et al. (2011) Role for inducible cAMP early repressor in promoting pancreatic beta cell dysfunction evoked by oxidative stress in human and rat islets. Diabetologia 54: 2337-2346.
20. Lopez S, Bermudez B, Abia R, Muriana FJ, (2010) The influence of major dietary fatty acids on insulin secretion and action. Curr Opin Lipidol 21: 15-20.
21. von Eckardstein A, Sibler RA, (2011) Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2. Curr Opin Lipidol 22: 26-32.
22. Kashyap VS, Santamarina-Fojo S, Brown DR, Parrott CL, Applebaum-Bowden D, et al. (1995) Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. The Journal of clinical investigation 96: 1612-1620.
23. Pellegrin M, Berthelot A, Houdayer C, Gaume V, Deckert V, et al. (2007) New insights into the vascular mechanisms underlying the beneficial effect of swimming training on the endothelial vasodilator function in apolipoprotein E-deficient mice. Atherosclerosis 190: 35-42.
24. Meyrelles SS, Peotta VA, Pereira TM, Vasquez EC, (2011) Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging. Lipids in health and disease 10: 211.
25. Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, et al. (2004) Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 145: 667-678.
26. Lilla V, Webb G, Rickenbach K, Maturana A, Steiner DF, et al. (2003) Differential gene expression in well-regulated and dysregulated pancreatic beta-cell (MIN6) sublines. Endocrinology 144: 1368-1379.
27. Ramirez-Zacarias JL, Castro-Munozledo F, Kuri-Harcuch W, (1992) Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry. 97: 493-497.
28. Guldenagel M, Ammermuller J, Feigenspan A, Teubner B, Degen J, et al. (2001) Visual transmission deficits in mice with targeted disruption of the gap junction gene connexin36. J Neurosci 21: 6036-6044.
29. Pellegrin M, Alonso F, Aubert JF, Bouzourene K, Braunersreuther V, et al. (2009) Swimming prevents vulnerable atherosclerotic plaque development in hypertensive 2-kidney, 1-clip mice by modulating angiotensin II type 1 receptor expression independently from hemodynamic changes. Hypertension 53: 782-789.
30. Allagnat F, Cunha D, Moore F, Vanderwinden JM, Eizirik DL, et al. (2011) Mcl-1 downregulation by pro-inflammatory cytokines and palmitate is an early event contributing to beta-cell apoptosis. Cell Death Differ 18: 328-337.
31. Molina CA, Foulkes NS, Lalli E, Sassone-Corsi P, (1993) Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell 75: 875-886.
32. Abderrahmani A, Cheviet S, Ferdaoussi M, Coppola T, Waeber G, et al. (2006) ICER induced by hyperglycemia represses the expression of genes essential for insulin exocytosis. EMBO J 25: 977-986.
33. Moore F, Colli ML, Cnop M, Esteve MI, Cardozo AK, et al. (2009) PTPN2, a candidate gene for type 1 diabetes, modulates interferon-gamma-induced pancreatic beta-cell apoptosis. Diabetes 58: 1283-1291.
34. Allagnat F, Fukaya M, Nogueira TC, Delaroche D, Welsh N, et al. (2012) C/EBP homologous protein contributes to cytokine-induced pro-inflammatory responses and apoptosis in beta-cells. Cell Death Differ.
35. Martin D, Allagnat F, Chaffard G, Caille D, Fukuda M, et al. (2008) Functional significance of repressor element 1 silencing transcription factor (REST) target genes in pancreatic beta cells. Diabetologia 51: 1429-1439.
36. Cardozo AK, Ortis F, Storling J, Feng YM, Rasschaert J, et al. (2005) Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. Diabetes 54: 452-461.
37. Nguidjoe E, Sokolow S, Bigabwa S, Pachera N, D'Amico E, et al. (2011) Heterozygous inactivation of the Na/Ca exchanger increases glucose-induced insulin release, beta-cell proliferation, and mass. Diabetes 60: 2076-2085.
38. Kusminski CM, Shetty S, Orci L, Unger RH, Scherer PE, (2009) Diabetes and apoptosis: lipotoxicity. Apoptosis: an international journal on programmed cell death 14: 1484-1495.
39. Hofker MH, van Vlijmen BJ, Havekes LM, (1998) Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis. Atherosclerosis 137: 1-11.
40. Veniant MM, Beigneux AP, Bensadoun A, Fong LG, Young SG, (2008) Lipoprotein size and susceptibility to atherosclerosis-insights from genetically modified mouse models. Curr Drug Targets 9: 174-189.
41. Meir KS, Leitersdorf E, (2004) Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 24: 1006-1014.
42. Jawien J, Nastalek P, Korbut R, (2004) Mouse models of experimental atherosclerosis. J Physiol Pharmacol 55: 503-517.
43. Stocker R, Keaney JF Jr, (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1381-1478.
44. Zhang SH, Reddick RL, Piedrahita JA, Maeda N, (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258: 468-471.
45. Robbesyn F, Garcia V, Auge N, Vieira O, Frisach MF, et al. (2003) HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells. Faseb J 17: 743-745.
46. de Souza JA, Vindis C, Negre-Salvayre A, Rye KA, Couturier M, et al. (2010) Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I. Journal of cellular and molecular medicine 14: 608-620.
47. Petremand J, Abderrahmani A, Widmann C, (2008) Genetics and molecular biology: HDLs and their multiple ways to protect cells. Curr Opin Lipidol 19: 95-97.
48. Petremand J, Puyal J, Chatton JY, Duprez J, Allagnat F, et al. (2012) HDLs protect pancreatic beta-cells against ER stress by restoring protein folding and trafficking. Diabetes 61: 1100-1111.
49. El-Assaad W, Buteau J, Peyot ML, Nolan C, Roduit R, et al. (2003) Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 144: 4154-4163.
50. Brasaemle DL, (2007) Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res 48: 2547-2559.
51. Pike LS, Smift AL, Croteau NJ, Ferrick DA, Wu M, (2011) Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta 1807: 726-734.